Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia
伊布替尼和维奈克拉作为有症状、初治华氏巨球蛋白血症的一线治疗
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2023022420
Castillo, Jorge J; Branagan, Andrew R; Sermer, David; Flynn, Catherine A; Meid, Kirsten; Little, Megan; Stockman, Katherine; White, Timothy; Canning, Alexa; Guerrera, Maria L; Kofides, Amanda; Liu, Shirong; Liu, Xia; Richardson, Kris; Tsakmaklis, Nicholas; Patterson, Christopher J; Hunter, Zachary R; Treon, Steven P; Sarosiek, Shayna